Torrent Pharmaceuticals (TORNTPHARM) — Announcement

📢 Key Event
Company dissolves Philippine subsidiary Curatio Inc. via Articles amendment

🔄 What Changed
Subsidiary removed from corporate structure

💡 Investor Takeaway
The dissolution has no material financial impact on the company.

Torrent Pharmaceuticals announced the voluntary dissolution of its Philippine subsidiary Curatio Inc. effective 10-Jul-26, confirmed on 17-Jul-26. The unit contributed negligible financials (Rs 1.3 Crores net worth, 0.02% of total) and dissolution was executed via Articles amendment without sale proceeds or related party transactions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — TORNTPHARM ✨ Ask AI About This

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

💡 Ask AI about this filing

"How does this dissolution affect Torrent's global R&D footprint?" "What is the expected impact on Q3 FY26 financials?" "Are there any tax implications from this subsidiary closure?"

Ask AI Free →

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

🔥 Also filed on 17 July 2026

WIPRO Wipro Limited Financial Results TATAELXSI Tata Elxsi Limited Financial Results TATATECH Tata Technologies Limited Financial Results JAYNECOIND Jayaswal Neco Industries Limited Financial Results FEDERALBNK The Federal Bank Limited Corporate Action UYFINCORP U. Y. Fincorp Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.